Assembly Biosciences Inc
NASDAQ:ASMB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Assembly Biosciences Inc
NASDAQ:ASMB
|
US |
|
Bourse Direct SA
F:BD6
|
FR |
|
A
|
Agritek Holdings Inc
OTC:AGTK
|
US |
|
Takashimaya Co Ltd
F:DC9
|
JP |
|
S
|
Sega Sammy Holdings Inc
XMUN:RYU
|
JP |
|
Keyera Corp
TSX:KEY
|
CA |
|
Akebia Therapeutics Inc
NASDAQ:AKBA
|
US |
Intrinsic Value
Is ASMB undervalued or overvalued?
See the intrinsic value estimate for Assembly Biosciences Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ASMB looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with ASMB’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Assembly Biosciences Does
Assembly Biosciences is a biotechnology company that develops medicines for viral diseases, especially hepatitis B and herpesvirus infections such as herpes simplex. It does not sell consumer products; its main job is to discover and test antiviral drug candidates in the lab and in clinical trials, then move the most promising ones forward toward approval.
- Headquarters
- United States of America US
- Employees
- 73
- IPO date
- Dec 17, 2010
Revenue & Expenses Breakdown
Assembly Biosciences Inc
Earnings Waterfall
Assembly Biosciences Inc
The intrinsic value for Assembly Biosciences Inc (ASMB) under the Base Case is hidden USD.
Compared with the current market price of 20.36 USD, the stock appears hidden.